Nigeria

FPwatch

The Government of Nigeria has made recent important advances in increasing access to and uptake of modern contraceptives. As part of its FP2020 commitments of achieving a contraceptive prevalence rate (CPR) of 36% by 2018, Nigeria has committed to providing an additional US$8.35 million annually over the next four years in addition to its current annual commitment of US$3 million, signifying an increase of nearly 300%. In addition, Nigeria has developed a detailed implementation plan to expand use of modern contraceptives and is effecting policy change and supporting task shifting that will enable community health workers to deliver a range of contraceptives. The private sector plays an important role in provision of health commodities and services in Nigeria, including regulated providers such as registered pharmacies and unregulated drug shops and retail ooutlets. 3

The 2015 baseline FPwatch Nigeria survey was integrated with the fourth round of ACTwatch outlet survey in six geo-political zones: South South (SS), South West (SW), South East (SE), North Central (NC), North West (NW), and North East (NE). Family planning survey modules were combined with malaria diagnostic and treatment modules for an integrated survey data collection that will serve both the family planning and malaria communities. The integrated fieldwork approach yields important learning to guide effective and efficient use of resources to provide timely, relevant, and high quality health market evidence for decision-making and policy setting. Data collection occurred in early fall of 2015, with more than 13,000 outlets considered for inclusion in the study.

See below for results! 

Published reports

1 National Population Commission. 2013. Nigeria Demographic and Health Survey 2013: Preliminary Report. Measure DHS, ICF International.

2 UNFPA, 2013: The state of world population 2013.

3 ACTwatch Group, SFH/Nigeria and the Independent Evaluation Team. (2012). ACTwatch Outlet Survey Report 2011 (Round 3).Endline Outlet Survey Report for the Independent Evaluation of Phase 1 of the Affordable Medicines Facility – malaria (AMFm): Nigeria. Abuja, Nigeria: ACTwatch/PSI/SFH Nigeria. 

Photo credit: Lindsay Mgbor, DFID